I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ylisaukko-Oja, Tero
56
results:
Search for persons
X
Format
Online (56)
Mediatypes
Articles (Online) (34)
Bookchapter (Online) (2)
OpenAccess-fulltext (20)
Languages
english (52)
finnish (2)
Sorted by: Relevance
Sorted by: Year
?
1
Real-life treatment persistence and treatment outcomes of F..:
Ylisaukko-oja, Tero
;
af Björkesten, Clas-Göran
;
Eberl, Anja
...
Heliyon. 10 (2024) 12 - p. e32432 , 2024
Link:
https://doi.org/10.1016/..
?
2
Comorbidity Burden in Severe and Nonsevere Asthma: A Nation..:
Kankaanranta, Hannu
;
Viinanen, Arja
;
Ilmarinen, Pinja
...
The Journal of Allergy and Clinical Immunology: In Practice. 12 (2024) 1 - p. 135-145.e9 , 2024
Link:
https://doi.org/10.1016/..
?
3
Epidemiology of myasthenia gravis in Denmark, Finland and S..:
Vissing, John
;
Atula, Sari
;
Savolainen, Mari
...
Journal of Neurology, Neurosurgery & Psychiatry. , 2024
Link:
https://doi.org/10.1136/..
?
4
Real-world treatment outcomes and safety of natalizumab in ..:
Verkkoniemi-Ahola, Auli
;
Hartikainen, Päivi
;
Hassi, Katja
...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9 (2023) 4 - p. , 2023
Link:
https://doi.org/10.1177/..
?
5
The association between body mass index groups and metaboli..:
Vesikansa, Aino
;
Mehtälä, Juha
;
Mutanen, Katja
...
Journal of Market Access & Health Policy. 11 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1080/..
?
6
Obesity and metabolic state are associated with increased h..:
Vesikansa, Aino
;
Mehtälä, Juha
;
Mutanen, Katja
...
The European Journal of Health Economics. 24 (2022) 5 - p. 769-781 , 2022
Link:
https://doi.org/10.1007/..
?
7
Early start of anti-dementia medication is associated with ..:
Vesikansa, Aino
;
Halminen, Olli
;
Mehtälä, Juha
...
The European Journal of Health Economics. 24 (2022) 9 - p. 1421-1428 , 2022
Link:
https://doi.org/10.1007/..
?
8
Effectiveness of mepolizumab in patients with severe eosino..:
Koistinen, Ville
;
Kauppi, Paula
;
Idänpään-Heikkilä, Juhana
...
Journal of Asthma. 59 (2022) 12 - p. 2375-2385 , 2022
Link:
https://doi.org/10.1080/..
?
9
The association of body mass index with quality of life and..:
Vesikansa, Aino
;
Mehtälä, Juha
;
Jokelainen, Jari
...
Quality of Life Research. 31 (2021) 2 - p. 413-423 , 2021
Link:
https://doi.org/10.1007/..
?
10
Benefit of measuring vedolizumab concentrations in inflamma..:
Kolehmainen, Sara
;
Ylisaukko-oja, Tero
;
Jokelainen, Jari
...
Scandinavian Journal of Gastroenterology. 56 (2021) 8 - p. 906-913 , 2021
Link:
https://doi.org/10.1080/..
?
11
Characterization of inflammatory bowel disease management b..:
Ylisaukko-oja, Tero
;
Torvinen, Saku
;
Aaltonen, Jaakko
...
Biologicals. 58 (2019) - p. 50-56 , 2019
Link:
https://doi.org/10.1016/..
?
12
Primary health care utilisation and its costs among middle-..:
Keto, Jaana
;
Ventola, Hanna
;
Jokelainen, Jari
...
The European Journal of Health Economics. 18 (2017) 3 - p. 351-360 , 2017
Link:
https://www.jstor.org/st..
?
13
Evaluation of Treatment Persistence of Vedolizumab among Fi..:
Ylisaukko-Oja, Tero
;
Eberl, Anja
;
Aaltonen, Jaakko
...
Gastroenterology. 152 (2017) 5 - p. S398 , 2017
Link:
https://doi.org/10.1016/..
?
14
Primary health care utilisation and its costs among middle-..:
Keto, Jaana
;
Ventola, Hanna
;
Jokelainen, Jari
...
The European Journal of Health Economics. 18 (2016) 3 - p. 351-360 , 2016
Link:
https://doi.org/10.1007/..
?
15
Physicians discuss the risks of smoking with their patients..:
Keto, Jaana
;
Jokelainen, Jari
;
Timonen, Markku
..
Substance Abuse Treatment, Prevention, and Policy. 10 (2015) 1 - p. , 2015
Link:
https://doi.org/10.1186/..
1-15